Literature DB >> 3104658

[Amphotericin B and flucytosine therapy of Aspergillus pneumonia and acute renal failure].

F Staib, I Bennhold, H W Voigt, C Bangel, A Blisse.   

Abstract

Kidney failure and pneumonia by Aspergillus flavus and A. fumigatus were found in a 56-year-old woman who had received antibiotic and corticoid treatment to control high fever. Her bloody tracheal secretion was a suspension of granule-like spore-free colonies of both Aspergillus species. Hemorrhages in mucous membranes and skin suggested a hematogenous dissemination of the fungi. Aspergillus spores in the soil of ornamental plants were assumed to be responsible for the inhalatory infection. The kidney function normalized rapidly under treatment by amphotericin B plus flucytosine and hemodialysis performed eight times. After 29 days of antimycotic treatment (amphotericin B 463 mg, flucytosine 150 g), besides normalization of the kidney function, healing of the pneumonia and bleeding from skin and mucal membranes took place. One and a half years later kidney function and blood parameters were found to be normal. In cases of Aspergillus pneumonia and kidney failure, a combined treatment by hemodialysis and amphotericin B plus flucytosine is recommended. In addition, there is discussion of the general importance of uremia and its influence on the mycotic infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3104658     DOI: 10.1007/bf01785527

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  11 in total

1.  Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man.

Authors:  E R Block; J E Bennett; L G Livoti; W J Klein; R R MacGregor; L Henderson
Journal:  Ann Intern Med       Date:  1974-05       Impact factor: 25.391

2.  [Residual serum nitrogen-auxanogram (with yeasts and molds)].

Authors:  F Staib
Journal:  Zentralbl Bakteriol Orig       Date:  1964-11

Review 3.  Chemiluminescence as a tool for the evaluation of antimicrobial agents: a review.

Authors:  R A Fromtling; G K Abruzzo
Journal:  Methods Find Exp Clin Pharmacol       Date:  1985-09

4.  Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.

Authors:  R L Kaspar; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

5.  [Fatal aspergillosis after infarction-induced pneumonia. A contribution to the epidemiology, diagnosis and prevention of aspergillosis of the lungs (author's transl)].

Authors:  F Staib; D Bohl; B Foth; S K Mishra; C Rajendran; J A Müller
Journal:  Prax Klin Pneumol       Date:  1980-12

Review 6.  [Chemotherapy of aspergillus lung disease].

Authors:  H J Scholer
Journal:  Mykosen       Date:  1983-04

7.  [Drug-monitoring of 5-fluorocytosine in serum by high-performance liquid chromatography (author's transl)].

Authors:  L Essers; D Hantschke; K H Leisse
Journal:  Mykosen       Date:  1982-04

8.  Effect of uremia on lymphocyte transformation and chemiluminescence by spleen cells of normal and Cryptococcus neoformans-infected mice.

Authors:  R A Fromtling; A M Fromtling; F Staib; S Müller
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

9.  Successful treatment of pulmonary and cerebral aspergillosis in an immunosuppressed child.

Authors:  G Henze; P Aldenhoff; U Stephani; G Grosse; E Kazner; F Staib
Journal:  Eur J Pediatr       Date:  1982-05       Impact factor: 3.183

10.  [Peracute disseminated course of fatal Aspergillus fumigatus infection in liver failure and corticoid therapy. A case report on the epidemiology, pathogenesis and diagnosis of the systemic course of Aspergillus infections].

Authors:  G Grosse; M L'Age; F Staib
Journal:  Klin Wochenschr       Date:  1985-06-03
View more
  2 in total

1.  Potted plants in hospitals as reservoirs of pathogenic fungi.

Authors:  R C Summerbell; S Krajden; J Kane
Journal:  Mycopathologia       Date:  1989-04       Impact factor: 2.574

2.  Syndrome of the anterior spinal artery as the primary manifestation of aspergillosis.

Authors:  B Pfausler; A Kampfl; K Berek; H Maier; F Aichner; E Schmutzhard
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.